Lv71
4965 积分 2021-05-09 加入
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan
2小时前
已完结
Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights
2小时前
待确认
Mechanisms and rationales of SAM homeostasis
1个月前
已完结
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan
2个月前
已关闭
Trabectedin in Cancers: Mechanisms and Clinical Applications
3个月前
已完结
皖公网安备34019202002308
